Premier Inc - Ordinary Shares - Class A

NASDAQ:PINC   3:59:54 PM EDT
38.82
-0.02 (-0.05%)
Earnings Announcements

Premier Inc And 11 Leading Health Systems Invest In Exela Pharma Sciences To Secure And Support U.S.- Based Drug Supply And Manufacturing

Published: 09/08/2021 11:45 GMT
Premier Inc - Ordinary Shares - Class A (PINC) - Premier Inc. and 11 Leading Health Systems Invest in Exela Pharma Sciences to Secure and Support U.S.- Based Drug Supply and Manufacturing.
Premier - New Initiative Will Manufacture Pharmaceutical Products in North Carolina, Primarily Using Apis From U.S. and Europe.
Premier Inc - Financial Terms of Transaction With Exela Were Not Disclosed.
Premier Inc - Transaction is Not Expected to Materially Impact Premier's Fiscal Year 2022 Financial Results.
Premier - Participating Premier Member Health Systems Are Expected to Have Uninterrupted Supply of 19 Pharmaceutical Products.
Revenue is expected to be $347 Million
Adjusted EPS is expected to be $0.60

Next Quarter Revenue Guidance is expected to be $343.92 Million
Next Quarter EPS Guidance is expected to be $0.64

More details on our Analysts Page.